Anyone going back on Perjeta due to positive APHINITY results?

Hi all,

In case you haven't heard, the preliminary APHINITY trial results are available: Perjeta improves invasive disease-free survival when given adjuvantly (with chemo and Herceptin). http://www.roche.com/media/store/releases/med-cor-...

In that study, Perjeta was given for an entire year along with Herceptin. Many of us only received four to six doses of Perjeta.

I was wondering if doctors are recommending that patients who have finished chemo but are currently taking Herceptin resume taking Perjeta for the balance of the year.

Thanks for any information you can provide.

Stephanie